Recombinant 2019-nCoV Nucleocapsid Protein

Artikelnummer: EBT-EPT266
Artikelname: Recombinant 2019-nCoV Nucleocapsid Protein
Artikelnummer: EBT-EPT266
Hersteller Artikelnummer: EPT266
Alternativnummer: EBT-EPT266-500
Hersteller: ELK Biotechnology
Kategorie: Proteine/Peptide
Alternative Synonym: 2019-nCoV coronavirus NP Protein, 2019-nCoV np Protein, 2019-nCoV novel coronavirus Nucleoprotein Protein
Recombinant SARS-CoV-2 Nucleocapsid Protein is produced by our E.coli expression system and the target gene encoding Met1-Ala419 is expressed with a 6His tag at the N-terminus.
Molekulargewicht: Molecular weight: 49.4kDa. Apparent molecular weight: 50-60kDa, reducing conditions
UniProt: QHD43423.2
Reinheit: Greater than 95% as determined by reducing SDS-PAGE.
Anwendungsbeschreibung: Biological activity: Immobilized 2019-nCoV Nucleocapsid Protein-His(CatDRA31)at 2µg/ml (100µl/well) can bind 2019-nCoV NP Antibody (6G9)(CatDA027). The ED50 of 2019-nCoV NP Antibody (6G9)(CatDA027) is 5-30 ng/ml. Background: Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool